Selective anti-Toxoplasma gondii activities of azasterols

International Journal of Antimicrobial Agents

Volumn 23, Issue 6, 2004, Pages 620-626

  Dantas Leite, Lucas ^a   Urbina, Julio A ^b   De Souza, Wanderley ^a   Vommaro, Rossiane C ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

Azasterols; Mitochrondrial activity; T. gondii; Ultrastructure

Indexed keywords

22,26 AZASTEROL; 24,25 EPIMINOLANOSTEROL; ANTIPARASITIC AGENT; STEROL DERIVATIVE; UNCLASSIFIED DRUG;

APICOPLAST; ARTICLE; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; GAS CHROMATOGRAPHY; IC 50; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MITOCHONDRION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REDUCTION; TOXOPLASMA GONDII; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CELL LINE; CELL MEMBRANE; CHOLESTANOL; COCCIDIOSTATS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; LANOSTEROL; MACACA MULATTA; METHYLTRANSFERASES; MITOCHONDRIA; PARASITIC SENSITIVITY TESTS; PHAGOSOMES; STEROLS; TOXOPLASMA;

EID: 2942670126     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.11.005     Document Type: Article

References (22)

1. Luder C.G., Bohne W., Soldati D. Toxoplasmosis: a persisting challenge. Trends Parasitol. 17:2001;460-463
2. Wilder H.P. Toxoplasma chorioretinitis in adults. Arch. Ophthalmol. 48:1952;127-136
3. Perkins E.S. Ocular toxoplasmosis. Br. J. Ophtalmol. 57:1973;1-17
4. Nussenblatt RB, Whitcup SM, Palestine AG. Ocular toxoplasmosis. In: Nussenblatt RB, Whitcup SM, Palestine AG, editors. Uveitis: fundamentals and clinical Practice. St. Louis. MO: Mosby-Year Book; 1996.
5. Luft B.J., Remington J.S. Toxoplasmic encephalilitisin AIDS. Clin. Infect. Dis. 15:1992;211-222
6. Mack D., McLeod R. New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparision of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A. Antimicrob Agents Chemother. 26:1984;26-30
7. Alder J, Hutch T, Jonathan A, Meulbroek Clement, CJ. Treatment of experimental Toxoplasma gondii Infection by clarithromycin-based combination therapy with minocycline or pyrimethamine. J Acquir Immune Defic Syndr 1994;7:1141-8.
8. Haverkos HW. Assessment of therapy for toxoplasma encephalitis. The TE Study Group. Am J Med 1987;82:907-14.
9. Aspinall T.V., Joynson D.H., Guy E., Hyde J.E., Sims P.F. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis. J. Infect. Dis. 185:2002;1643-1673
10. 24(25)-sterol methyltranferase block sterol synthesis and cell proliferation in Pneumocystis carinii. Antimicrob. Agents Chemother. 41:1997;1428-1432
11. 24(25)-sterol methyltranferase inhibitors and their combinations with ketoconazole. Int. J. Antimicrob. Agents. 7:1996;235-240
12. 24(25)-sterol methyltranferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis. Antimicrob. Agents Chemother. 46:2002;487-499
13. Vannier-Santos M.A., Urbina J.A., Martiny A., Neves A., de Souza W. Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania. J. Eukaryot. Microbiol. 42:1995;337-346
14. Urbina J.A. Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites. Parasitology. 114:1997;S91-S99
15. Foussard F., Gallois Y., Girault A., Menez J.F. Lipids and fatty acids of tachyzoites and purified pellicles of Toxoplasma gondii. Parasitol Res. 77:1991;475-477
16. Coppens I., Sinai A.P., Joiner K.A. Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition. J. Cell Biol. 149:2000;167-180
17. Melo E.J., Attias M., De Souza W. The single mitochondrion of tachyzoites of Toxoplasma gondii. J Struct Biol. 130:2000;27-33
18. Parish E.J., Nes W.D. Synthesis of new epiminoisopentenoids. Synthet. Commun. 18:1988;221-226
19. Martin MB, Grimley JS, Lewis JC, et al. Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy. J Med Chem 2001;15:909-16.
20. De Araujo Jorge T.C., De Souza W. Effect of carbohydrates, periodate and enzymes in the process of endocytosis of Trypanosoma cruzi by macrophages. Acta Trop. 41:1984;17-28
21. 24(25)-sterol methyltranferase inhibitors and their combinations with ketoconazole. Mol. Biochem. Parasitol. 73:1995;199-210
22. Dubey J.P., Lindsay D.S., Speer C. Structures of Toxoplasma gondii taquizoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol. Rev. 11:1998;267-299